Rheumatoid Arthritis Research Program Awardees
Since 2021, the Arthritis Foundation’s Rheumatoid Arthritis (RA) Research Program has invested in innovative research aimed at uncovering the underlying causes of RA, improving treatment outcomes and advancing prevention strategies. The Foundation’s awardees represent leading researchers across the country whose work is helping drive progress in understanding disease progression, treatment-resistant RA and the immune system mechanisms behind this complex autoimmune disease.
2025 RA Research Program Awardees
Learn more in our press release.
Anna Helena Jonsson, MD, PhD, University of Colorado at Denver
$450,000
Defining the antigen specificities and spatial organization of synovial CD8 T cells in RA
Read about Anna Helena Jonsson
Kevin Wei, MD, PhD, Brigham and Women’s Hospital
$450,000
Targeting neurotrophins in refractory rheumatoid arthritis
Read about Kevin Wei
Megan Hanlon, PhD, Brigham and Women’s Hospital
$150,000
The inflamed synovium as a trigger for trained immunity in RA
Read about Megan Hanlon
Marla Glass, PhD, Allen Institute
$149,567
Kinetics of autoreactive B cells during the progression to rheumatoid arthritis
Read about Marla Glass
Robert Corty, MD, PhD, Vanderbilt University
$150,000
Defining rheumatoid arthritis phenotypes through the lens of clonal hematopoiesis
Read about Robert Corty (link soon)
Past RA Grant Awardees
2024
Tom (Thomas) Riley, MD, Penn Medicine
$150,000
Using polygenic risk for disease susceptibility to predict disease severity and treatment response in patients with rheumatoid arthritis
Read more about Thomas Riley
Aryana Sepassi, PharmD, University of California, Irvine
$150,000
Effects of Socioeconomic and Racial/Ethnic Status on Biologic Disease-Modifying Antirheumatic Agents for Medicare Beneficiaries
Read more about Aryana Sepassi
Fan Zhang, PhD, University of Colorado Anschutz Medical Campus
$149,557
Uncovering dynamic immunophenotypes by developing novel AI methods to predict RA onset
Read more about Dr. Zhang’s work
Mehmet Hocaoğlu, MD, University of Pittsburgh Medical Center
$150,000
Genetic and Environmental Risk Factors for Progression to Rheumatoid Arthritis Using Machine Learning Model Predictions
Read more about Dr. Hocaoğlu's work
Chris (Christopher) Striebich, MD, University of Colorado Anschutz Medical Campus
$448,662
National Network to Prospectively Study Individuals at Risk for Rheumatoid Arthritis
Read more about Christopher Striebich
Jeff (Jeffrey) Sparks, MD, Brigham and Women's Hospital
$450,000
Cellular Biomarkers for Risk and Progression of Subclinical Interstitial Lung Disease in Early Rheumatoid Arthritis
Read more about Jeffrey Sparks
2023
Learn more in our press release
Michael George, MD
Institution: University of Pennsylvania
Grant title: Genetic predictors of metabolic adverse effects with glucocorticoid treatment in patients with rheumatoid arthritis
Award mechanism: Pilot award
Amount awarded: $150,000 Award duration: 1 year
Read more about Dr. George
Wen-Yuan Elena Hsieh, MD
Institution: University of Colorado, Denver
Grant title: Immunological determinants of the development of clinical rheumatoid arthritis evaluated in the pre-RA and early stages of disease
Award mechanism: Large award
Amount awarded: $450,000
Award duration: 2 years
Read more about Dr. Hsieh
Theresa Wampler Muskardin, MD
Institution: Hospital for Special Surgery
Grant title: Examination of Pathotype-specific Biology and Treatment Response using Microbioengineered and Rheumatoid Arthritis Patient-Derived Synovium-on-a-Chip
Award mechanism: Large award
Amount awarded: $450,000
Award duration: 2 years
Read more about Dr. Wampler Muskardin
2022
Rebecca Blank, MD, PhD
Institution: New York University Grossman School of Medicine
Grant title: Modifying the gut microbiome and systemic immune response to enhance methotrexate efficacy in rheumatoid arthritis patients with inadequate response
Award mechanism: Pilot award
Amount awarded: $74,995
Award duration: 1 year
Read more about Dr. Blank
Susan Goodman, MD
Institution: Hospital for Special Surgery
Grant title: Characterizing Targets in Refractory RA
Award mechanism: Large award
Amount awarded: $450,000
Award duration: 3 years
Read more about Dr. Goodman
Elaine Husni, MD, MPH
Institution: Cleveland Clinic
Grant title: Defining a Personalized
Treatment Approach to Rheumatoid Arthritis: Using Genetic Markers of TNFi Response
Award mechanism: Pilot award
Amount awarded: $75,000
Award duration: 1 year
Read more about Dr. Husni
Dan Solomon, MD, MPH
Institution: Brigham and Women's Hospital, Inc.
Grant title: Defining immune cell phenotypes and cell functions that distinguish treatment responders and non-responders in RA: towards development of a liquid biopsy to personalize treatment
Award mechanism: Large award
Amount awarded: $450,000
Award duration: 3 years
Read more about Dr. Solomon
Sign Up for This E-Newsletter
Tell us a little about yourself and subscribe to Joint Matters.
